Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Lee VH, Kwong DL, Leung TW, Choi CW, O'Sullivan B, Lam KO, Lai V, Khong PL, Chan SK, Ng CY, Tong CC, Ho PP, Chan WL, Wong LS, Leung DK, Chan SY, So TH, Luk MY, Lee AW. Lee VH, et al. Among authors: luk my. Int J Cancer. 2019 Apr 1;144(7):1713-1722. doi: 10.1002/ijc.31856. Epub 2018 Dec 24. Int J Cancer. 2019. PMID: 30192385 Clinical Trial.
Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
Chan SK, Lin C, Huang SH, Chau TC, Guo QJ, O'Sullivan B, Lam KO, Chau SC, Chan SY, Tong CC, Vardhanabhuti V, Kwong DLW, So TH, Ng CY, Leung TW, Luk MY, Lee AWM, Choi HCW, Pan JJ, Lee VHF. Chan SK, et al. Among authors: luk my. Oral Oncol. 2022 Mar;126:105736. doi: 10.1016/j.oraloncology.2022.105736. Epub 2022 Feb 1. Oral Oncol. 2022. PMID: 35121396
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies.
Chan SK, Chan SY, Tong CC, Lam KO, Kwong DL, Leung TW, Luk MY, Lee AW, Choi HC, Lee VH. Chan SK, et al. Among authors: luk my. Oral Oncol. 2021 Mar;114:105158. doi: 10.1016/j.oraloncology.2020.105158. Epub 2021 Jan 25. Oral Oncol. 2021. PMID: 33508707
Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong-A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network.
Chan SK, Chau SC, Chan SY, Tong CC, Lam KO, Lai-Wan Kwong D, Leung TW, Luk MY, Lee AW, Choi HC, Lee VH. Chan SK, et al. Among authors: luk my. Cancer Control. 2021 Jan-Dec;28:10732748211047117. doi: 10.1177/10732748211047117. Cancer Control. 2021. PMID: 34565216 Free PMC article.
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
Chan SK, O'Sullivan B, Huang SH, Chau TC, Lam KO, Chan SY, Tong CC, Vardhanabhuti V, Kwong DL, Ng CY, Leung TW, Luk MY, Lee AW, Choi HC, Lee VH. Chan SK, et al. Among authors: luk my. Cancers (Basel). 2022 Apr 11;14(8):1923. doi: 10.3390/cancers14081923. Cancers (Basel). 2022. PMID: 35454830 Free PMC article.
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Chan SK, Chan SY, Choi HC, Tong CC, Lam KO, Kwong DL, Vardhanabhuti V, Leung TW, Luk MY, Lee AW, Lee VH. Chan SK, et al. Among authors: luk my. Front Oncol. 2020 Aug 21;10:1417. doi: 10.3389/fonc.2020.01417. eCollection 2020. Front Oncol. 2020. PMID: 32974150 Free PMC article.
34 results